Catalyst Pharmaceuticals (CPRX) Asset Utilization Ratio (2018 - 2026)

Catalyst Pharmaceuticals' Asset Utilization Ratio history runs 9 years deep, the most recent figure standing at 0.53 for Q1 2026.

• Quarterly Asset Utilization Ratio fell 12.71% year-over-year to 0.53 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.53 (down 12.71% YoY) and the FY2025 annual result came in at 0.6, down 19.05% from the prior year.
• Asset Utilization Ratio was 0.53 for Q1 2026 at Catalyst Pharmaceuticals, down from 0.55 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.9 in Q4 2023 and bottomed at 0.53 in Q1 2026.
• A 5-year average of 0.65 and a median of 0.63 in 2022 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2023 — Asset Utilization Ratio surged 49.16% — and 2024, when it plunged 32.81%.
• Catalyst Pharmaceuticals' Asset Utilization Ratio stood at 0.6 in 2022, then jumped by 49.16% to 0.9 in 2023, then plunged by 32.81% to 0.61 in 2024, then retreated by 9.79% to 0.55 in 2025, then dropped by 2.97% to 0.53 in 2026.
• Business Quant data shows CPRX's Asset Utilization Ratio at 0.53 in Q1 2026, 0.55 in Q4 2025, and 0.57 in Q3 2025.